ZYVERSA THERAPEUTICS, INC. Basic Shares Outstanding (Weighted Average)
ZYVERSA THERAPEUTICS, INC. (ZVSA) reported Basic Shares Outstanding (Weighted Average) of 8.10 million shares for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-05-13
- ZYVERSA THERAPEUTICS, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 8.10M shares, a 160.58% increase year-over-year.
- ZYVERSA THERAPEUTICS, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 8.14M shares, a 308.95% increase year-over-year.
- ZYVERSA THERAPEUTICS, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 7.74M shares, a 683.17% increase year-over-year.
- ZYVERSA THERAPEUTICS, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-06-30 was 4.81M shares, a 476.60% increase year-over-year.
- ZYVERSA THERAPEUTICS, INC. weighted average number of shares outstanding, basic for fiscal 2025 was 5.96M shares, a 437.28% increase from fiscal 2024.
- ZYVERSA THERAPEUTICS, INC. weighted average number of shares outstanding, basic for fiscal 2024 was 1.11M shares, a 1038.50% increase from fiscal 2023.
- ZYVERSA THERAPEUTICS, INC. weighted average number of shares outstanding, basic for fiscal 2023 was 97.50K shares.
| Period end | Weighted Average Number of Shares Outstanding, Basic 1 month | Weighted Average Number of Shares Outstanding, Basic 1 month as first filed | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic 11 month | Weighted Average Number of Shares Outstanding, Basic 12 month | Weighted Average Number of Shares Outstanding, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 8.10M shares 10-Q · filed 2026-05-13 | 8.12M shares derived: average of 2 quarters · filed 2026-05-13 | 7.99M shares derived: average of 3 quarters · filed 2026-05-13 | 7.20M shares derived: average of 4 quarters · filed 2026-05-13 | |||||||
| 2025-12-31 | 8.14M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | 7.94M shares derived: average of 2 quarters · filed 2026-03-31 | 6.90M shares derived: average of 3 quarters · filed 2026-03-31 | 5.96M shares 10-K · filed 2026-03-31 | |||||||
| 2025-09-30 | 7.74M shares 10-Q · filed 2025-11-19 | 6.28M shares derived: average of 2 quarters · filed 2025-11-19 | 5.24M shares 10-Q · filed 2025-11-19 | 4.41M shares derived: average of 4 quarters · filed 2026-05-13 | |||||||
| 2025-06-30 | 4.81M shares 10-Q · filed 2025-08-13 | 3.97M shares 10-Q · filed 2025-08-13 | 3.30M shares derived: average of 3 quarters · filed 2026-05-13 | 2.73M shares derived: average of 4 quarters · filed 2026-05-13 | |||||||
| 2025-03-31 | 3.11M shares 10-Q · filed 2026-05-13 | 2.55M shares derived: average of 2 quarters · filed 2026-05-13 | 2.03M shares derived: average of 3 quarters · filed 2026-05-13 | 1.73M shares derived: average of 4 quarters · filed 2026-05-13 | |||||||
| 2024-12-31 | 1.99M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | 1.49M shares derived: average of 2 quarters · filed 2026-03-31 | 1.27M shares derived: average of 3 quarters · filed 2026-03-31 | 1.11M shares 10-K · filed 2026-03-31 | |||||||
| 2024-09-30 | 988.38K shares 10-Q · filed 2025-11-19 | 911.65K shares derived: average of 2 quarters · filed 2025-11-19 | 816.29K shares 10-Q · filed 2025-11-19 | 665.44K shares derived: average of 4 quarters · filed 2025-11-19 | |||||||
| 2024-06-30 | 834.91K shares 10-Q · filed 2025-08-13 | 729.31K shares 10-Q · filed 2025-08-13 | 557.79K shares derived: average of 3 quarters · filed 2025-08-13 | 442.66K shares derived: average of 4 quarters · filed 2025-08-13 | |||||||
| 2024-03-31 | 623.60K shares 10-Q · filed 2025-05-12 | 419.23K shares derived: average of 2 quarters · filed 2025-05-12 | 311.90K shares derived: average of 3 quarters · filed 2025-05-12 | 246.68K shares derived: average of 4 quarters · filed 2025-05-12 | |||||||
| 2023-12-31 | 214.86K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | 156.06K shares derived: average of 2 quarters · filed 2025-03-27 | 121.04K shares derived: average of 3 quarters · filed 2025-03-27 | 97.50K shares 10-K · filed 2025-03-27 | 975.03K shares 10-K · filed 2024-03-25 | ||||||
| 2023-09-30 | 97.25K shares 10-Q · filed 2024-11-14 | 30.98M shares 10-Q · filed 2023-11-14 | 74.13K shares derived: average of 2 quarters · filed 2024-11-14 | 58.38K shares 10-Q · filed 2024-11-14 | 19.40M shares 10-Q · filed 2023-11-14 | ||||||
| 2023-06-30 | 51.02K shares 10-Q · filed 2024-08-09 | 17.86M shares 10-Q · filed 2023-08-21 | 38.62K shares 10-Q · filed 2024-08-09 | 13.52M shares 10-Q · filed 2023-08-21 | |||||||
| 2023-03-31 | 26.08K shares 10-Q · filed 2024-05-15 | 9.13M shares 10-Q · filed 2023-05-12 | |||||||||
| 2022-12-31 | 257.60K shares 10-K · filed 2024-03-25 | 9.02M shares 10-K · filed 2023-03-31 | |||||||||
| 2022-12-12 | 24.19M shares 10-K · filed 2024-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |